Navegando por Palavras-chave "Ilhotas"

Agora exibindo 1 - 1 de 1
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Transplante de pâncreas e ilhotas em portadores de diabetes melito
    (Sociedade Brasileira de Endocrinologia e Metabologia, 2008-03-01) Sá, João Roberto de [UNIFESP]; Gonzalez, Adriano Miziara [UNIFESP]; Melaragno, Cláudio Santiago [UNIFESP]; Saitovich, David; Franco, Denise Reis; Rangel, Erika Bevilaqua [UNIFESP]; Noronha, Irene Lourdes; Pestana, Jose Osmar Medina [UNIFESP]; Bertoluci, Marcelo Casaccia; Linhares, Marcelo Moura [UNIFESP]; Miranda, Marcelo Perosa de; Monteagudo, Patricia [UNIFESP]; Genzini, Tércio; Eliaschewitz, Freddy Goldberg; Universidade Federal de São Paulo (UNIFESP); Pontifícia Universidade Católica do Rio Grande do Sul Hospital São Lucas Serviço de Nefrologia; Universidade de São Paulo (USP); Sistema de Saúde Centro de Pesquisa Médica Notre-Dame Intermédica; Universidade Federal do Rio Grande do Sul Departamento de Medicina Interna; Hospital Israelita Albert Einstein Serviço de Transplante de Pâncreas
    Pancreas and kidney transplants have specific indications, benefits and risks. The procedure has become more common and more often as long-term success has improved and risks have decreased. Compared with a patient being on dialysis, simultaneous pancreas-kidney transplant offers a distinct advantage when it comes to mortality, quality of life and diabetic complications. Since there can be a living-donor kidney transplant,, a possibly similar patient and graft survival by 10 years follow-up, this procedure should be considered. Pancreas after kidney transplants, when successful, can improve microvascular complications compared with kidney transplant alone, but immediate mortality may be higher. Solitary pancreas transplantation can improve the quality of life in selected patients, but it may also increase the immediate risk of mortality due to the complexity of the surgery and the risks of immunosupression. The results of Islet transplantation differ from the higher metabolic performance achieved by whole pancreas allotransplantation and its applicability is limited to selected adult diabetic patients.